CLINICAL_TRIALS
other
· 2016-01-22
Clinical Trial Update: Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer. [Phase 2]
Summary
A Phase 2 trial evaluating neoadjuvant afatinib for early-stage non-small cell lung cancer has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: SUSPENDED